Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.00 is 100% below its 3-year average of 0.04, around the middle of its 3-year range (-0.26–0.36).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
0.00
DEBT TO EQUITY RATIO AVG 3Y
0.04
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13
median of 562 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Autonomix Medical, Inc.
Market Cap
$1.93M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.04
5Y Avg
N/A
Market Cap
$2.32M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$1.49M
Debt to Equity Ratio
0.83
TTM Avg
0.17
3Y Avg
0.16
5Y Avg
0.13
Market Cap
$1.44M
Debt to Equity Ratio
0.24
TTM Avg
0.63
3Y Avg
2.77
5Y Avg
1.75
Market Cap
$1.46M
Debt to Equity Ratio
0.02
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | $1.93M | 0.00 | 0.00 | 0.04 | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | 0.18 | 0.11 | 0.06 | 0.04 |
| Onconetix, Inc. (ONCO)vs › | $2.25M | 0.01 | 0.49 | 0.33 | 0.20 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 0.00 | 0.00 | 0.00 | 0.00 |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | 0.83 | 0.17 | 0.16 | 0.13 |
| Curis, Inc. (CRIS)vs › | $1.47M | 0.22 | 0.30 | 0.17 | 0.13 |
| INVO Fertility, Inc. (IVF)vs › | $1.44M | 0.24 | 0.63 | 2.77 | 1.75 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | 0.02 | N/A | N/A | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.43M | 1.51 | 0.59 | 0.51 | 3.40 |
| NewcelX Ltd. (NCEL)vs › | $1.43M | 0.06 | 0.03 | 0.02 | 0.01 |
Debt/Equity
0.00
Current Ratio
4.85
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.00 |
| 2026-03-31 | 0.00 |
| 2025-12-31 | 0.00 |
| 2025-09-30 | 0.00 |
| 2025-06-30 | 0.00 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.12 |
| 2024-09-30 | 0.36 |
| 2024-06-30 | 0.20 |
| 2024-03-31 | 0.13 |
| 2023-12-31 | -0.26 |
| 2023-09-30 | -0.02 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
